Protein Frontiers ApS: Financial statements 2023
CVR: 43132709
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Protein Frontiers ApS (CVR 43132709) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 609,925 and a net result of DKK 545,732. Equity in the 2023 report amounted to DKK 465,241. The solvency ratio was 35.5%.
- Gross Profit
- DKK 609,925
- Profit/Loss
- DKK 545,732
- Equity
- DKK 465,241
- Total Assets
- DKK 1,310,864
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Protein Frontiers ApS has published its interim report for the period March 10, 2022 – December 31, 2022.
About Protein Frontiers ApS
Protein Frontiers ApS is a Danish company of the type Anpartsselskab based in Gentofte, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Henrik Sønksen. The board consists of Niels Kristian Sørensen (chair), Peter Lübeck, Hans Peder Morten Laursen Meldgaard and Henrik Sønksen. The company's owners include MPLU Biorefining Aps, NKS Investment ApS and H Sønksen Holding ApS. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 513,139 and a net result of DKK -149,320 compared with DKK 601,274 the year before. Equity in the 2025 report amounted to DKK 1,183,824.